Audentes Therapeutics
- Biological Products, Except Diagnostic Substances
- San Francisco, California
Compensation history
Top executives at Audentes Therapeutics received an average of $2M per person in annual compensation from 2015 to 2018.
Average pay of disclosed executives at Audentes Therapeutics
By year
- 2018
NH$1MNatalie HollesPresident and Chief Operating OfficerMP$780KMatthew PattersonChief Executive OfficerSP$560KSuyash PrasadSenior Vice President and Chief Medical OfficerJG$527KJohn GraySenior Vice President and Chief Technology OfficerTS$525KThomas SolowayExecutive Vice President and Chief Financial Officer
Executives
We found six executives who work or worked at Audentes Therapeutics.
Matthew Patterson
Audentes Therapeutics
Chief Executive Officer
Thomas Soloway
Audentes Therapeutics
Chief Financial Officer
Natalie Holles
Audentes Therapeutics
Chief Operating Officer
Suyash Prasad
Audentes Therapeutics
Chief Medical Officer
John Gray
Audentes Therapeutics
Chief Technology Officer
Tom Soloway
Audentes Therapeutics
Chief Financial Officer
News
About Audentes Therapeutics
- Industry classifications
- DivisionManufacturing
- Major groupChemicals And Allied Products
- Industry groupDrugs
- IndustryBiological Products, Except Diagnostic Substances
- Address600 California St., 17th Floor, San Francisco, California 94108
- Phone415-638-6556
- Fiscal year endDecember 31
Source: SEC filings on April 26, 2019, April 27, 2018, and April 27, 2017.